{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:48:20Z","timestamp":1789073300519,"version":"build-2803163510"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005149","name":"CAMS | Cancer Institute and Hospital, Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-021"],"award-info":[{"award-number":["2021-I2M-1-021"]}],"id":[{"id":"10.13039\/501100005149","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005149","name":"CAMS | Cancer Institute and Hospital, Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-018"],"award-info":[{"award-number":["2021-I2M-1-018"]}],"id":[{"id":"10.13039\/501100005149","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005149","name":"CAMS | Cancer Institute and Hospital, Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-010"],"award-info":[{"award-number":["2021-I2M-1-010"]}],"id":[{"id":"10.13039\/501100005149","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005149","name":"CAMS | Cancer Institute and Hospital, Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2023-I2M-2-004"],"award-info":[{"award-number":["2023-I2M-2-004"]}],"id":[{"id":"10.13039\/501100005149","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82350113"],"award-info":[{"award-number":["82350113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National High Level Hospital Clinical Research Funding"},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02858-3","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:26:31Z","timestamp":1783351591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor-draining lymph nodes shape the tumor microenvironment through enrichment of tumor-reactive effector-exhausted CD8+ T cells"],"prefix":"10.1038","volume":"11","author":[{"given":"Deyang","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialiang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyi","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renshen","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaibing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5201-6432","authenticated-orcid":false,"given":"Wei","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengdian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1433-3482","authenticated-orcid":false,"given":"Haizeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"2858_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","volume":"21","author":"KJ Hiam-Galvez","year":"2021","unstructured":"Hiam-Galvez, K. J., Allen, B. M. & Spitzer, M. H. Systemic immunity in cancer. Nat. Rev. Cancer21, 345\u2013359 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"2858_CR2","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","volume":"186","author":"MK Rahim","year":"2023","unstructured":"Rahim, M. K. et al. Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes. Cell186, 1127\u20131143.e18 (2023).","journal-title":"Cell"},{"key":"2858_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.immuni.2022.12.002","volume":"56","author":"N Prokhnevska","year":"2023","unstructured":"Prokhnevska, N. et al. CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor. Immunity56, 107\u2013124.e5 (2023).","journal-title":"Immunity"},{"key":"2858_CR4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41586-024-08076-7","volume":"636","author":"MA Cardenas","year":"2024","unstructured":"Cardenas, M. A. et al. Differentiation fate of a stem-like CD4 T cell controls immunity to cancer. Nature636, 224\u2013232 (2024).","journal-title":"Nature"},{"key":"2858_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/science.adq1405","volume":"388","author":"K Jobin","year":"2025","unstructured":"Jobin, K. et al. A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals. Science388, eadq1405 (2025).","journal-title":"Science"},{"key":"2858_CR6","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124507","volume":"3","author":"MF Fransen","year":"2018","unstructured":"Fransen, M. F. et al. Tumor-draining lymph nodes are pivotal in PD-1\/PD-L1 checkpoint therapy. JCI Insight3, e124507 (2018).","journal-title":"JCI Insight"},{"key":"2858_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","volume":"168","author":"MH Spitzer","year":"2017","unstructured":"Spitzer, M. H. et al. Systemic immunity is required for effective cancer immunotherapy. Cell168, 487\u2013502.e15 (2017).","journal-title":"Cell"},{"key":"2858_CR8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ccell.2020.09.001","volume":"38","author":"F Dammeijer","year":"2020","unstructured":"Dammeijer, F. et al. The PD-1\/PD-L1-checkpoint restrains T cell immunity in tumor-draining lymph nodes. Cancer Cell38, 685\u2013700.e8 (2020).","journal-title":"Cancer Cell"},{"key":"2858_CR9","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","volume":"138","author":"CR Boland","year":"2010","unstructured":"Boland, C. R. & Goel, A. Microsatellite instability in colorectal cancer. Gastroenterology138, 2073\u20132087.e3 (2010).","journal-title":"Gastroenterology"},{"key":"2858_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrclinonc.2009.237","volume":"7","author":"E Vilar","year":"2010","unstructured":"Vilar, E. & Gruber, S. B. Microsatellite instability in colorectal cancer-the stable evidence. Nat. Rev. Clin. Oncol.7, 153\u2013162 (2010).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2858_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","volume":"16","author":"K Ganesh","year":"2019","unstructured":"Ganesh, K. et al. Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat. Rev. Gastroenterol. Hepatol.16, 361\u2013375 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2858_CR12","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","volume":"18","author":"MJ Overman","year":"2017","unstructured":"Overman, M. J. et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol.18, 1182\u20131191 (2017).","journal-title":"Lancet Oncol."},{"key":"2858_CR13","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le, D. T. et al. PD-1 blockade in tumors with mismatch-repair deficiency. N. Engl. J. Med.372, 2509\u20132520 (2015).","journal-title":"N. Engl. J. Med."},{"key":"2858_CR14","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9, T. et al. Pembrolizumab in microsatellite-instability\u2013high advanced colorectal cancer. N. Engl. J. Med.383, 2207\u20132218 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2858_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1200\/JCO.19.02107","volume":"38","author":"DT Le","year":"2020","unstructured":"Le, D. T. et al. Phase II open-label study of pembrolizumab in treatment-refractory, microsatellite instability-high\/mismatch repair-deficient metastatic colorectal cancer: KEYNOTE-164. J. Clin. Oncol.38, 11\u201319 (2020).","journal-title":"J. Clin. Oncol."},{"key":"2858_CR16","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","volume":"26","author":"M Chalabi","year":"2020","unstructured":"Chalabi, M. et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat. Med.26, 566\u2013576 (2020).","journal-title":"Nat. Med."},{"key":"2858_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S2468-1253(21)00348-4","volume":"7","author":"H Hu","year":"2022","unstructured":"Hu, H. et al. Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial. Lancet Gastroenterol. Hepatol.7, 38\u201348 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"2858_CR18","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","volume":"386","author":"A Cercek","year":"2022","unstructured":"Cercek, A. et al. PD-1 blockade in mismatch repair\u2013deficient, locally advanced rectal cancer. N. Engl. J. Med.386, 2363\u20132376 (2022).","journal-title":"N. Engl. J. Med."},{"key":"2858_CR19","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","volume":"184","author":"K Pelka","year":"2021","unstructured":"Pelka, K. et al. Spatially organized multicellular immune hubs in human colorectal cancer. Cell184, 4734\u20134752.e20 (2021).","journal-title":"Cell"},{"key":"2858_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.422","volume":"11","author":"Y Mei","year":"2021","unstructured":"Mei, Y. et al. Single-cell analyses reveal suppressive tumor microenvironment of human colorectal cancer. Clin. Transl. Med.11, e422 (2021).","journal-title":"Clin. Transl. Med."},{"key":"2858_CR21","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","volume":"181","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell181, 442\u2013459.e29 (2020).","journal-title":"Cell"},{"key":"2858_CR22","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41588-020-0636-z","volume":"52","author":"H-O Lee","year":"2020","unstructured":"Lee, H.-O. et al. Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer. Nat. Genet.52, 594\u2013603 (2020).","journal-title":"Nat. Genet."},{"key":"2858_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","volume":"564","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature564, 268\u2013272 (2018).","journal-title":"Nature"},{"key":"2858_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54710-3","volume":"15","author":"Y Feng","year":"2024","unstructured":"Feng, Y. et al. Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients. Nat. Commun.15, 10259 (2024).","journal-title":"Nat. Commun."},{"key":"2858_CR25","doi-asserted-by":"publisher","first-page":"e0019","DOI":"10.1097\/MD.0000000000010019","volume":"97","author":"S Kang","year":"2018","unstructured":"Kang, S. et al. The significance of microsatellite instability in colorectal cancer after controlling for clinicopathological factors. Medicine97, e0019 (2018).","journal-title":"Medicine"},{"key":"2858_CR26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","volume":"20","author":"AM van der Leun","year":"2020","unstructured":"van der Leun, A. M., Thommen, D. S. & Schumacher, T. N. CD8+ T cell states in human cancer: insights from single-cell analysis. Nat. Rev. Cancer20, 218\u2013232 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"2858_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","volume":"23","author":"G Oliveira","year":"2023","unstructured":"Oliveira, G. & Wu, C. J. Dynamics and specificities of T cells in cancer immunotherapy. Nat. Rev. Cancer23, 295\u2013316 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"2858_CR28","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1084\/jem.20180684","volume":"215","author":"J Brummelman","year":"2018","unstructured":"Brummelman, J. et al. High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors. J. Exp. Med.215, 2520\u20132535 (2018).","journal-title":"J. Exp. Med."},{"key":"2858_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","volume":"50","author":"I Siddiqui","year":"2019","unstructured":"Siddiqui, I. et al. Intratumoral Tcf1+PD-1+CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity50, 195\u2013211.e10 (2019).","journal-title":"Immunity"},{"key":"2858_CR30","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller, B. C. et al. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade. Nat. Immunol.20, 326\u2013336 (2019).","journal-title":"Nat. Immunol."},{"key":"2858_CR31","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1016\/j.cell.2022.09.020","volume":"185","author":"Q Huang","year":"2022","unstructured":"Huang, Q. et al. The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes. Cell185, 4049\u20134066.e25 (2022).","journal-title":"Cell"},{"key":"2858_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adg1094","volume":"9","author":"SA Minnie","year":"2024","unstructured":"Minnie, S. A. et al. TIM-3+ CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies. Sci. Immunol.9, eadg1094 (2024).","journal-title":"Sci. Immunol."},{"key":"2858_CR33","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.it.2023.02.006","volume":"44","author":"R Zander","year":"2023","unstructured":"Zander, R. & Cui, W. Exhausted CD8+ T cells face a developmental fork in the road. Trends Immunol.44, 276\u2013286 (2023).","journal-title":"Trends Immunol."},{"key":"2858_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ajpath.2011.03.007","volume":"179","author":"D Coppola","year":"2011","unstructured":"Coppola, D. et al. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. Am. J. Pathol.179, 37\u201345 (2011).","journal-title":"Am. J. Pathol."},{"key":"2858_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.2834","volume":"15","author":"M Kurachi","year":"2014","unstructured":"Kurachi, M. et al. The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells. Nat. Immunol.15, 373\u2013383 (2014).","journal-title":"Nat. Immunol."},{"key":"2858_CR36","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.ccell.2024.06.009","volume":"42","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer. Cancer Cell42, 1268\u20131285.e7 (2024).","journal-title":"Cancer Cell"},{"key":"2858_CR37","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1126\/science.abl5447","volume":"375","author":"FJ Lowery","year":"2022","unstructured":"Lowery, F. J. et al. Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers. Science375, 877\u2013884 (2022).","journal-title":"Science"},{"key":"2858_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adh9562","volume":"15","author":"Z Meng","year":"2023","unstructured":"Meng, Z. et al. Transcriptome-based identification of tumor-reactive and bystander CD8+ T cell receptor clonotypes in human pancreatic cancer. Sci. Transl. Med.15, eadh9562 (2023).","journal-title":"Sci. Transl. Med."},{"key":"2858_CR39","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ccell.2022.03.005","volume":"40","author":"C Zheng","year":"2022","unstructured":"Zheng, C. et al. Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers. Cancer Cell40, 410\u2013423.e7 (2022).","journal-title":"Cancer Cell"},{"key":"2858_CR40","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s43018-022-00433-7","volume":"3","author":"B Liu","year":"2022","unstructured":"Liu, B., Zhang, Y., Wang, D., Hu, X. & Zhang, Z. Single-cell meta-analyses reveal responses of tumor-reactive CXCL13+ T cells to immune-checkpoint blockade. Nat. Cancer3, 1123\u20131136 (2022).","journal-title":"Nat. Cancer"},{"key":"2858_CR41","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/s43018-021-00269-7","volume":"2","author":"AR Parikh","year":"2021","unstructured":"Parikh, A. R. et al. Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial. Nat. Cancer2, 1124\u20131135 (2021).","journal-title":"Nat. Cancer"},{"key":"2858_CR42","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ccell.2024.12.008","volume":"43","author":"A Acha-Sagredo","year":"2025","unstructured":"Acha-Sagredo, A. et al. A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancer. Cancer Cell43, 292\u2013307.e7 (2025).","journal-title":"Cancer Cell"},{"key":"2858_CR43","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","volume":"171","author":"N Riaz","year":"2017","unstructured":"Riaz, N. et al. Tumor and microenvironment evolution during immunotherapy with nivolumab. Cell171, 934\u2013949.e16 (2017).","journal-title":"Cell"},{"key":"2858_CR44","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1158\/0008-5472.CAN-16-3556","volume":"77","author":"A Prat","year":"2017","unstructured":"Prat, A. et al. Immune-related gene expression profiling after PD-1 blockade in non-small cell lung carcinoma, head and neck squamous cell carcinoma, and melanoma. Cancer Res.77, 3540\u20133550 (2017).","journal-title":"Cancer Res."},{"key":"2858_CR45","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.immuni.2019.10.009","volume":"51","author":"R Zander","year":"2019","unstructured":"Zander, R. et al. CD4+ T cell help is required for the formation of a cytolytic CD8+ T cell subset that protects against chronic infection and cancer. Immunity51, 1028\u20131042.e4 (2019).","journal-title":"Immunity"},{"key":"2858_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq6509","volume":"7","author":"R Reschke","year":"2022","unstructured":"Reschke, R. & Gajewski, T. F. CXCL9 and CXCL10 bring the heat to tumors. Sci. Immunol.7, eabq6509 (2022).","journal-title":"Sci. Immunol."},{"key":"2858_CR47","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.trecan.2018.09.001","volume":"4","author":"JP B\u00f6ttcher","year":"2018","unstructured":"B\u00f6ttcher, J. P. & Reis e Sousa, C. The role of type 1 conventional dendritic cells in cancer immunity. Trends Cancer4, 784\u2013792 (2018).","journal-title":"Trends Cancer"},{"key":"2858_CR48","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","volume":"42","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis. Cancer Cell42, 1370\u20131385.e9 (2024).","journal-title":"Cancer Cell"},{"key":"2858_CR49","doi-asserted-by":"publisher","first-page":"e002101","DOI":"10.1136\/jitc-2020-002101","volume":"9","author":"J-P Li","year":"2021","unstructured":"Li, J.-P. et al. PD-1 + CXCR5 \u2212 CD4 + Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma. J. Immunother. Cancer9, e002101 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"2858_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ccell.2020.11.006","volume":"39","author":"C Lu","year":"2021","unstructured":"Lu, C. et al. DNA sensing in mismatch repair-deficient tumor cells is essential for anti-tumor immunity. Cancer Cell39, 96\u2013108.e6 (2021).","journal-title":"Cancer Cell"},{"key":"2858_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adh2334","volume":"9","author":"T Zhang","year":"2024","unstructured":"Zhang, T. et al. Up-regulated PLA2G10 in cancer impairs T cell infiltration to dampen immunity. Sci. Immunol.9, eadh2334 (2024).","journal-title":"Sci. Immunol."},{"key":"2858_CR52","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.immuni.2018.11.014","volume":"50","author":"S Kurtulus","year":"2019","unstructured":"Kurtulus, S. et al. Checkpoint blockade immunotherapy induces dynamic changes in PD-1\u2212CD8+ tumor-infiltrating T cells. Immunity50, 181\u2013194.e6 (2019).","journal-title":"Immunity"},{"key":"2858_CR53","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","volume":"175","author":"M Sade-Feldman","year":"2018","unstructured":"Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell175, 998\u20131013.e20 (2018).","journal-title":"Cell"},{"key":"2858_CR54","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","volume":"176","author":"H Li","year":"2019","unstructured":"Li, H. et al. Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma. Cell176, 775\u2013789.e18 (2019).","journal-title":"Cell"},{"key":"2858_CR55","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41590-022-01338-4","volume":"23","author":"JR Giles","year":"2022","unstructured":"Giles, J. R. et al. Shared and distinct biological circuits in effector, memory and exhausted CD8+ T cells revealed by temporal single-cell transcriptomics and epigenetics. Nat. Immunol.23, 1600\u20131613 (2022).","journal-title":"Nat. Immunol."},{"key":"2858_CR56","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/imr.12405","volume":"271","author":"M-C Dieu-Nosjean","year":"2016","unstructured":"Dieu-Nosjean, M.-C. et al. Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers. Immunol. Rev.271, 260\u2013275 (2016).","journal-title":"Immunol. Rev."},{"key":"2858_CR57","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1158\/1078-0432.CCR-21-1130","volume":"28","author":"M Lauss","year":"2022","unstructured":"Lauss, M., Donia, M., Svane, I. M. & J\u00f6nsson, G. B Cells and tertiary lymphoid structures: friends or foes in cancer immunotherapy? Clin. Cancer Res.28, 1751\u20131758 (2022).","journal-title":"Clin. Cancer Res."},{"key":"2858_CR58","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1378844","volume":"7","author":"F Posch","year":"2018","unstructured":"Posch, F. et al. Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer. Oncoimmunology7, e1378844 (2018).","journal-title":"Oncoimmunology"},{"key":"2858_CR59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jtho.2023.09.1443","volume":"19","author":"C Jiang","year":"2024","unstructured":"Jiang, C., Zhang, Y., Fu, F., Deng, P. & Chen, H. A shift in paradigm: selective lymph node dissection for minimizing oversurgery in early stage lung cancer. J. Thorac. Oncol.19, 25\u201335 (2024).","journal-title":"J. Thorac. Oncol."},{"key":"2858_CR60","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","volume":"25","author":"KE Yost","year":"2019","unstructured":"Yost, K. E. et al. Clonal replacement of tumor-specific T cells following PD-1 blockade. Nat. Med.25, 1251\u20131259 (2019).","journal-title":"Nat. Med."},{"key":"2858_CR61","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","volume":"56","author":"I Mellman","year":"2023","unstructured":"Mellman, I., Chen, D. S., Powles, T. & Turley, S. J. The cancer-immunity cycle: Indication, genotype, and immunotype. Immunity56, 2188\u20132205 (2023).","journal-title":"Immunity"},{"key":"2858_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21241-0","volume":"12","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. Targeting IL-21 to tumor-reactive T cells enhances memory T cell responses and anti-PD-1 antibody therapy. Nat. Commun.12, 951 (2021).","journal-title":"Nat. Commun."},{"key":"2858_CR63","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.immuni.2022.01.018","volume":"55","author":"R Zander","year":"2022","unstructured":"Zander, R. et al. Tfh-cell-derived interleukin 21 sustains effector CD8+ T cell responses during chronic viral infection. Immunity55, 475\u2013493.e5 (2022).","journal-title":"Immunity"},{"key":"2858_CR64","doi-asserted-by":"publisher","first-page":"1369743","DOI":"10.3389\/fimmu.2024.1369743","volume":"15","author":"G Isvoranu","year":"2024","unstructured":"Isvoranu, G. & Chiritoiu-Butnaru, M. Therapeutic potential of interleukin-21 in cancer. Front. Immunol.15, 1369743 (2024).","journal-title":"Front. Immunol."},{"key":"2858_CR65","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","volume":"69","author":"H Harlin","year":"2009","unstructured":"Harlin, H. et al. Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Cancer Res.69, 3077\u20133085 (2009).","journal-title":"Cancer Res."},{"key":"2858_CR66","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature11522","volume":"491","author":"H Shin","year":"2012","unstructured":"Shin, H. & Iwasaki, A. A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature491, 463\u2013467 (2012).","journal-title":"Nature"},{"key":"2858_CR67","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","volume":"26","author":"IG House","year":"2020","unstructured":"House, I. G. et al. Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade. Clin. Cancer Res.26, 487\u2013504 (2020).","journal-title":"Clin. Cancer Res."},{"key":"2858_CR68","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.immuni.2019.04.010","volume":"50","author":"MT Chow","year":"2019","unstructured":"Chow, M. T. et al. Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy. Immunity50, 1498\u20131512.e5 (2019).","journal-title":"Immunity"},{"key":"2858_CR69","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","volume":"10","author":"J Kwon","year":"2020","unstructured":"Kwon, J. & Bakhoum, S. F. The cytosolic DNA-sensing cGAS-STING pathway in cancer. Cancer Discov.10, 26\u201339 (2020).","journal-title":"Cancer Discov."},{"key":"2858_CR70","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ccell.2020.11.004","volume":"39","author":"J Guan","year":"2021","unstructured":"Guan, J. et al. MLH1 deficiency-triggered DNA hyperexcision by exonuclease 1 activates the cGAS-STING pathway. Cancer Cell39, 109\u2013121.e5 (2021).","journal-title":"Cancer Cell"},{"key":"2858_CR71","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13046-025-03544-y","volume":"44","author":"W-J Li","year":"2025","unstructured":"Li, W.-J. et al. The cGAS\u2012STING pathway in colorectal cancer: bridging innate immunity and therapeutic strategies. J. Exp. Clin. Cancer Res.44, 286 (2025).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2858_CR72","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1007\/s00262-022-03200-w","volume":"71","author":"A Kaneta","year":"2022","unstructured":"Kaneta, A. et al. Role of the cGAS-STING pathway in regulating the tumor-immune microenvironment in dMMR\/MSI colorectal cancer. Cancer Immunol. Immunother.71, 2765\u20132776 (2022).","journal-title":"Cancer Immunol. Immunother."},{"key":"2858_CR73","doi-asserted-by":"publisher","first-page":"eabg3551","DOI":"10.1126\/sciimmunol.abg3551","volume":"6","author":"H du Bois","year":"2021","unstructured":"du Bois, H., Heim, T. A. & Lund, A. W. Tumor-draining lymph nodes: At the crossroads of metastasis and immunity. Sci. Immunol.6, eabg3551 (2021).","journal-title":"Sci. Immunol."},{"key":"2858_CR74","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008026","volume":"12","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Tumor-draining lymph nodes: opportunities, challenges, and future directions in colorectal cancer immunotherapy. J. Immunother. Cancer12, e008026 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"2858_CR75","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trecan.2023.09.006","volume":"10","author":"I Delclaux","year":"2024","unstructured":"Delclaux, I., Ventre, K. S., Jones, D. & Lund, A. W. The tumor-draining lymph node as a reservoir for systemic immune surveillance. Trends Cancer10, 28\u201337 (2024).","journal-title":"Trends Cancer"},{"key":"2858_CR76","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"2858_CR77","doi-asserted-by":"publisher","first-page":"47","DOI":"10.12688\/f1000research.22139.1","volume":"9","author":"N Borcherding","year":"2020","unstructured":"Borcherding, N., Bormann, N. L. & Kraus, G. scRepertoire: an R-based toolkit for single-cell immune receptor analysis. F1000Res. 9, 47 (2020).","journal-title":"F1000Res"},{"key":"2858_CR78","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"2858_CR79","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol.32, 381\u2013386 (2014).","journal-title":"Nat. Biotechnol."},{"key":"2858_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun.12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"2858_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep.7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"2858_CR82","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","volume":"40","author":"DM Cable","year":"2022","unstructured":"Cable, D. M. et al. Robust decomposition of cell type mixtures in spatial transcriptomics. Nat. Biotechnol.40, 517\u2013526 (2022).","journal-title":"Nat. Biotechnol."},{"key":"2858_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02663-5","volume":"23","author":"J Tanevski","year":"2022","unstructured":"Tanevski, J., Flores, R. O. R., Gabor, A., Schapiro, D. & Saez-Rodriguez, J. Explainable multiview framework for dissecting spatial relationships from highly multiplexed data. Genome Biol.23, 97 (2022).","journal-title":"Genome Biol."},{"key":"2858_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i08","volume":"28","author":"T Hothorn","year":"2008","unstructured":"Hothorn, T., Hornik, K., Wiel, M. A. V. D. & Zeileis, A. Implementing a class of permutation tests: the coin package. J. Stat. Softw.28, 1\u201323 (2008).","journal-title":"J. Stat. Softw."},{"key":"2858_CR85","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","volume":"19","author":"T Chen","year":"2021","unstructured":"Chen, T. et al. The genome sequence archive family: toward explosive data growth and diverse data types. Genom. Proteom. Bioinform.19, 578\u2013583 (2021).","journal-title":"Genom. Proteom. Bioinform."},{"key":"2858_CR86","unstructured":"CNCB-NGDC Members and Partners. Database resources of the National Genomics Data Center, China National Center for Bioinformation in 2024. Nucleic Acids Res. 52, D18\u2013D32 (2024)."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02858-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02858-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02858-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:02:00Z","timestamp":1783357320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02858-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2858"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02858-3","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"273"}}